The past, present and future in scaffold-based tendon treatments
Date
2015-04Author
Lomas, A.J.
Ryan, C.N.M.
Sorushanova, A.
Shologu, N.
Sideri, A.I.
Tsioli, V.
Fthenakis, G.C.
Tzora, A.
Skoufos, I.
Quinlan, Leo R.
Ó Laighin, Gearóid
Mullen, A.M.
Kelly, A.M.
Kearns, J.L.
Biggs, S.
Pandit, Abhay
Zeugolis, Dimitrios I.
Metadata
Show full item recordUsage
This item's downloads: 1372 (view details)
Cited 100 times in Scopus (view citations)
Recommended Citation
Lomas, A. J., Ryan, C. N. M., Sorushanova, A., Shologu, N., Sideri, A. I., Tsioli, V. Fthenakis, G. C., Tzora, A., Skoufos, I., Quinlan, L. R., O'Laighin, G., Mullen, A. M., Kelly, J. L., Kearns, S., Biggs, M., Pandit, A. , Zeugolis, D. I. (2015). The past, present and future in scaffold-based tendon treatments. Advanced Drug Delivery Reviews, 84, 257-277. doi: https://doi.org/10.1016/j.addr.2014.11.022
Published Version
Abstract
Tendon injuries represent a significant clinical burden on healthcare systems worldwide. As the human population ages and the life expectancy increases, tendon injuries will become more prevalent especially among young individuals with long life ahead of them. Advancements in engineering, chemistry and biology have made available an array of three-dimensional scaffold-based intervention strategies, natural or synthetic in origin. Further, functionalisation strategies, based on biophysical, biochemical and biological cues, offer control over cellular functions; localisation and sustained release of therapeutics/biologics; and the ability to positively interact with the host to promote repair and regeneration. Herein, we critically discuss current therapies and emerging technologies that aim to transform tendon treatments in the years to come. (C) 2014 Elsevier B.V. All rights reserved.
Collections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland
Related items
Showing items related by title, author, creator and subject.
-
Preferential tendon stem cell response to growth factor supplementation.
Holladay, Carolyn; Abbah, Sunny-Akogwu (Wiley, 2014)Tendon injuries are increasingly prevalent around the world, accounting for more than 100 000 new clinical cases/year in the USA alone. Cell-based therapies have been proposed as a therapeutic strategy, with recent data ... -
Assessment of stem cell carriers for tendon tissue engineering in pre-clinical models
Abbah, Sunny; Spanoudes, Kyriakos; O’Brien, Timothy; Pandit, Abhay; Zeugolis, Dimitrios I. (Springer Nature, 2014-01-01)Tendon injuries are prevalent and problematic, especially among young and otherwise healthy individuals. The inherently slow innate healing process combined with the inevitable scar tissue formation compromise functional ... -
Substrate topography: a valuable in vitro tool, but a clinical red herring for in vivo tenogenesis
English, Andrew; Azeem, Ayesha; Spanoudes, Kyriakos; Jones, Eleanor; Tripathi, Bhawana; Basu, Nandita; McNamara, Karrina; Tofail, Syed A.M.; Rooney, Niall; Riley, Graham; O’Riordan, Alan; Cross, Graham; Hutmacher, Dietmar; Biggs, Manus; Pandit, Abhay; Zeugolis, Dimitrios I. (Elsevier BV, 2015-11-01)